Turning Point Benefit Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3
Closed -$112 – 583
2025
Q4
$112 Hold
3
– – ﹤0.01% 801
2025
Q3
$122 Buy
+3
New +$99 ﹤0.01% 704

Other funds holding PAHC

Turning Point Benefit Group's PAHC Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 3 shares — an estimated $112 sold.

Turning Point Benefit Group first reported a position in PAHC in Q3 2025 and held it in 2 quarters. The position peaked at $122 in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 3 Phibro Animal Health shares in Q1 2026, an estimated $112.
  • Turning Point Benefit Group first reported a position in Phibro Animal Health in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Phibro Animal Health position peaked at $122 in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.